An In-Silico and In-Vitro Study of Imatinib and Naringin Combination for Inhibiting P-Glycoprotein and Delaying Drug Resistance in Chronic Myeloid Leukemia. AJP. 2023;17(2). doi:10.22377/ajp.v17i2.4859